A shared vision for better regulatory science: – Moving toward the light at the end of the tunnel

31 January 2019

This week in London, Medicines for Europe gathers regulators and […]

Efficient use of pharmacovigilance data essential for patient safety

30 January 2019

National authorities, regulators, industry leaders, and stakeholders gathered in London […]

Competition policy essential for access to medicines

28 January 2019

Medicines for Europe welcomes the publication of the European Commission […]

Crucial European Parliament vote vastly improves SPC manufacturing waiver

23 January 2019

Medicines for Europe welcomes today’s vote of the Legal Committee […]

Interview: Adrian van den Hoven, Director General of Medicines for Europe

8 January 2019

Over the last ten years, generic medicines have increased access […]

Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver

4 December 2018

The Medicines for Europe Board unanimously applauds last night’s vote […]

Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines

30 November 2018

Yesterday, 29th November, members of the Competitiveness Council expressed strong […]

Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI)

27 November 2018

The introduction of comprehensive SPC manufacturing waiver key to unlocking […]

Health at a Glance Report highlights public value of generic, biosimilar and value added medicines

26 November 2018

The European Commission and OECD – Health at a Glance: […]

Driving local excellence, delivering European results

5 November 2018

Medicines for Europe is glad to announce the occasion of […]

Newsroom

News about

By type

Twitter

Videos

Photos

A shared vision for better regulatory science: – Moving toward the light at the end of the tunnel

31 January 2019

Efficient use of pharmacovigilance data essential for patient safety

30 January 2019

Competition policy essential for access to medicines

28 January 2019

Crucial European Parliament vote vastly improves SPC manufacturing waiver

23 January 2019

Interview: Adrian van den Hoven, Director General of Medicines for Europe

8 January 2019

Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver

4 December 2018

Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines

30 November 2018

Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI)

27 November 2018

Health at a Glance Report highlights public value of generic, biosimilar and value added medicines

26 November 2018

Driving local excellence, delivering European results

5 November 2018

Subscribe to our newsletter

Share on Mastodon